Skip to content
Use caution Drug recall · FDA · Published May 25, 2023

Golden State Medical Supply: Travoprost Ophthalmic Solution Recall Due to Sterility Risk

Golden State Medical Supply recalls Travoprost Ophthalmic Solution (0.004%) due to missing tamper seal on secondary container. This may cause infection. Stop using and contact your doctor.

🇺🇸 FDA recall #D-0867-2023DrugGolden State Medical Supply ›
Take action

Contact the company

Recalling firmGolden State Medical Supply Inc.5187 Camino Ruiz · Camarillo, CA 93012-8601
✎ GovInfoNow plain-language explainer

Golden State Medical Supply is recalling Travoprost Ophthalmic Solution (0.004%) because the secondary container lacks a tamper seal. This could lead to infection if the product is not sterile. Read more at govinfonow.com/recall/33429-golden-state-medical-supply-travoprost-ophthalmic-solution-recall-due-to.

Source Summary by GovInfoNow · govinfonow.com/recall/33429-golden-state-medical-supply-travoprost-ophthalmic-solution-recall-due-to · Updated September 23, 2026 · FDA enforcement record: FDA #D-0867-2023

Cite this page

“Golden State Medical Supply: Travoprost Ophthalmic Solution Recall Due to Sterility Risk.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/33429-golden-state-medical-supply-travoprost-ophthalmic-solution-recall-due-to. Based on FDA recall #D-0867-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0867-2023%22&limit=1).

The FDA announced on May 25, 2023, that Golden State Medical Supply Inc. is recalling Travoprost Ophthalmic Solution due to a missing tamper-evident seal on the secondary container, which raises sterility concerns. The voluntary Class II recall affects 1,920 bottles distributed nationwide.

How to tell if you have it

  • Brand: Golden State Medical Supply
  • Product: Travoprost Ophthalmic Solution, USP (Ionic Buffered Solution), 0.004%, Rx only
  • Manufacturer: Apotex Inc. / GSMS Incorporated
  • NDC 51407-731-25 (2.5 mL bottle) with Lot #s GS049666, GS049807, Exp: 03/31/2024
  • NDC 51407-731-05 (5 mL bottle) with Lot #s GS049667, GS051447, Exp: 09/30/2024

The hazard

The recall addresses a lack of assurance of sterility because the tamper-evident seal is missing from the secondary container. The FDA classified this as a Class II recall, indicating that use of the product could cause serious health problems or death.

Context

GovInfoNow's records show Golden State Medical Supply Inc. has 31 other recalls on record since April 14, 2014. Recent brand recalls include Prasugrel HCl 10mg Tablets recalled on August 21, 2026, for failed dissolution specifications and Carbamazepine 200mg tablets recalled on August 7, 2026, due to CGMP deviations involving black specks. Other recent recalls of similar products include TRP Gentle Eyes Lubricant Eye Drops Recall (August 20, 2026), Geri-Care Eye Drops Recalled for Sterility Risk (March 25, 2026), and Thea Pharma Similasan Eye Drops Recall (April 23, 2026).

How to tell if you have this one

Check for bottles labeled with NDC 51407-731-25 (2.5 mL) or 51407-731-05 (5 mL). The lot numbers are GS049666, GS049807 (expiring 03/31/2024) or GS049667, GS051447 (expiring 09/30/2024).

  • Brand
    Golden State Medical Supply
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop Using Now

    Immediately stop using the recalled Travoprost Ophthalmic Solution if you have the specified lot numbers.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 2.2 years after the firm started it.

1. Firm started the recall: May 25, 202312. FDA classified it Class II: Jun 6, 202323. Published in FDA’s Enforcement Report: Jun 14, 202334. FDA terminated the recall: Aug 8, 2025420232025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Golden State Medical Supply recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0867-2023 (May 25, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0867-2023 to see it in context.
  • Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA